Evidence map›Paper›PMID 37326787›Full record

ArticleJournal of community genetics2023

"What if" should precede "whether" and "how" in the social conversation around human germline gene editing.

Diewertje Houtman, Wendy Geuverink, Isabel Rosalie Arianne Retel Helmrich, Boy Vijlbrief, Martina Cornel, Sam Riedijk

Abstract read
In one paragraph

Article in Journal of community genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Diewertje Houtman *Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0661-6466
Wendy Geuverink *Human Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0383-6711
Isabel Rosalie Arianne Retel HelmrichDepartment of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-5257-395X
Boy VijlbriefDepartment of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-4374-3002
Martina CornelHuman Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-5397-5544
Sam RiedijkDepartment of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands. s.riedijk@erasmusmc.nl.

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek NWA.1389.20.075
6 · The paper itself

Abstract

Given the potential large ethical and societal implications of human germline gene editing (HGGE) the urgent need for public and stakeholder engagement (PSE) has been repeatedly expressed. In this short communication, we aim to provide directions for broad and inclusive PSE by emphasizing the importance of futures literacy, which is a skill to imagine diverse and multiple futures and to use these as lenses to look at the present anew. By first addressing "what if" questions in PSE, different futures come into focus and limitations that arise when starting with the "whether" or "how" questions about HGGE can be avoided. Futures literacy can also aid in the goal of societal alignment, as "what if" questions can be answered in many different ways, thereby opening up the conversation to explore a multitude of values and needs of various publics. Broad and inclusive PSE on HGGE starts with asking the right questions.

Indexed as

Futures literacyHuman germline gene editingPublic engagementSocietal alignment

Identifiers

PMID37326787
PMCPMC10444910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.